UBS AM’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
UBS AM's IMRX Position: Q3 2026 in Review
UBS AM opened a new position in Immuneering (IMRX) in Q3 2026: 173 shares worth $708. The stake represents ﹤0.01% of the portfolio and ranks #4159 among its holdings.
112 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- UBS AM held 173 shares of Immuneering worth $708 as of Q3 2026.
- Immuneering was a new UBS AM position in Q3 2026.
- Immuneering made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4159 holding.
- 112 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.